CHD/Prevention News

Nanox announced its subsidiary, Nanox.AI, received FDA 510(k) clearance for its AI-powered coronary artery disease detection solution.

Neighborhoods with higher socioeconomic disadvantage, particularly predominantly Black areas, had higher rates of hypertension and lower rates of BP treatment vs. less disadvantaged neighborhoods, researchers reported.

Adults with subclinical hypothyroidism may have a lower risk for major adverse cardiovascular events if they receive levothyroxine therapy compared with no treatment, according to a study published in Thyroid.

A novel prognostic model identified risk factors including smoking, obesity, HbA1c and albuminuria as significant predictors of incident heart failure risk among Native American adults, researchers reported.

Adults with prediabetes and overweight or obesity have a 94% lower risk for developing type 2 diabetes with the once-weekly GIP/GLP-1 dual agonist tirzepatide vs. placebo, according to top-line results from the SURMOUNT-1 3-year study.

Years of exposure to loud noise in the workplace may increase the likelihood of developing high blood pressure, according to a study presented at the American College of Cardiology Asia Conference.

A platelet reactivity score that identifies people with a hyperreactive platelet phenotype can be used to determine those who might be at elevated risk for a cardiovascular event, researchers reported in Nature Communications.

Environmental sustainability is a critical global concern, as climate change and environmental degradation increasingly threaten human health and planetary well-being.

Benzodiazepines were associated with increased risk for CHD, HF and CV mortality among patients with insomnia, according to a study published in the European Journal of Preventive Cardiology.

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.